Antimicrobial resistance in Helicobacter pylori: A global overview

Acta Gastro-Enterologica Belgica

Volumn 61, Issue 3, 1998, Pages 357-366

  Glupczynski, Y ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; BISMUTH CITRATE; BISMUTH NITRATE; CLARITHROMYCIN; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CONFERENCE PAPER; GASTROINTESTINAL INFECTION; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; METHODOLOGY; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; PROGNOSIS;

EID: 0031693586     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (85)

1. VAN DER HULST R.W, KELLER J J.. RAUWS E.A., TYTGAT G.N. Treatment of Helicobacter pylori infection a review of the world literature. Helicobacter. 1996, 1 : 6-19
2. MÉGRAUD F. What is the relevance of resistance of Helicobacter pylori to antimicrobial agents ? In: HUNT R.H., TYTGAT G.N J. (editors). Helitobacter pylori . basic mechanisms, to clinical cure, 1996. Dordrecht : Kluwer academic publishers, 1996, 348-356.
3. MEGRAUD F Resistance of Helicobacter pylori to antibiotics Aliment. Pharmacol. Ther., 1997, 11 (Suppl. 1) : 43-53
4. GLUPCZYNSKI Y. Résistance de Helicobacter pylori aux agents antimicrobiens. In: MÉGRAUD F. LAMOULIATTE H. (editors). Helicobacter pylori Volume 2 ; Clinique et Traitement Amsterdam, Elsevier, 1997, 317-40
5. THE EUROPEAN HELICOBACTER PYLORI STUDY GROUP. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus report Gut, 1997, 41 : 8-13.
6. DE KOSTER E., COZZOLI A., VANDENBORRE C. et al Helicobacter pylori resistance to macrolides increases, to imidazole remains stable. Gastroenterology, 1997, 112 . A99.
7. LOPEZ-BREA M., DOMINGO D., SANCHEZ I., ALARCON T. Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain. J. Antimicrob. Chemother, 1997, 40. 279-81.
8. VAN DER WOUDEN E.J., VAN ZWET M , VOSMAER G.D., OOM J.A , DE JONG A., KLEIBEUKER J.H Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerg. Infect. Dis., 1997, 3 . 385-9.
9. LING T.K.W., CHENG A.F.B., SUNG J.J.Y., YIU P.Y.I., CHUNG S.S.C. An increase in Helicobacter pylori strains resistant to metronidazole ; a five-year study Helicobacter, 1996. 1 (1) : 57-61.
10. EDWARDS D.I Nitroimidazole drugs - action and resistance mechanisms 1. Mechanisms of action. J. Antimicrob Chemother., 1993, 31 : 9-20.
11. CEDERBRANT G., KAHIMETER G. LJUNGH A. A proposed mechanism for metronidazole resistance in H pylori. J. Antimicrob. Chemother., 1992, 29 . 115-20.
12. SMITH M A., EDWARDS D.I. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori. J. Antimicrob. Chemother., 1995, 36 : 453-61
13. SMITH M.A , EDWARDS D.I. Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori. J. Antimicrob. Chemother., 1997, 39 : 347-53
14. HOFFMAN P.S., GOODWIN A., KERSULYTE D., HAN H., VELDHUYZEN VAN ZANTEN S., BERG D.E. Proceedings of the conference on Helicobacter pylori : basic mechanisms to clinical cure. 1998 : 1998 January 19-21 : San Diego. USA.
15. MÉGRAUD F., OCCHIALINI A. Mode d'action des macrolides et mécanisme de résistance chez Helicobacter pylori Lettre Infectiol, 1997. 12 (Suppl. 3) : 5-9
16. WEISBLUM B Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother., 1995. 39 : 577-85
17. VERSALOVIC J., SHORTRIDGE D., KIBLER K. et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother., 1996, 40 : 477-80
18. DEBETS-OSSENKOP Y.J , SPARRIUS M., KUSTERS J.G., KOLKMAN J.J., VANDENBROUCKE-GRAULS C M J.E. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett., 1996, 142 : 37-42.
19. STONE G G., SHORTRIDGE D., FLAMM R.K et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter, 1996, 1 : 227-8.
20. OCCHIALINI A , URDACI M., DOUCET-POPULAIRE F , BÉBÉAR M C , LAMOULIATTE H., MÉGRAUD F. Macrolide resistance in Helicobacter pylori : rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob. Agents Chemother., 1997, 41 : 2724-8.
21. STONE G.G., SHORTRIDGE D., VERSALOVIC J. et al. A PCR-oligonueleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycinresistant Helicobacter pylori. Antimicrob. Agents Chemother . 1997, 41 . 712-4
22. HULTEN K., GIBREEL A., SKÖLD O., ENGSTRAND L Macrolide resistance in Helicobacter pylori . stability in strains from clarithromycintreated patients. Antimicrob. Agents Chemother., 1997, 41 : 2550-3
23. TAYLOR D.E., GE Z., PURYCH D., LO T, HIRATSUKA K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylon and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother., 1997. 41 : 2621-8.
24. SZCZEBARA F , DHAENENS L., VINCENT P., HUSSON M.O. Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori Eur J. Clin. Microbiol. Infect. Dis., 1997, 16 : 162-4.
25. PINA M., OCCHIALINI A., MONTEIRO L , DOERMANN H.P., MÉGRAU D F. Rapid detection of point mutations associated with macrolide resistance in H. pylori using the Gen-eti-k DEIA hybridization kit. Gut, 1997, 41 (Suppl. 1) : A75
26. MOORE R.A., BECKTHOLD B., WONG S., KUREISHI A., BRYAN L.E Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori Antimicrob. Agents Chemother , 1995, 39 : 107-111
27. KARIM Q.N., LOGAN R P.H The epidemiology of Helicobacter pylon antimicrobial resistance . preliminary findings of a national survey. Gut, 1995. 37 (Suppl. 2). A6.
28. PICCOLOMINI R., DI BONAVENTURA G, CATAMO G, CARBONE F., NERI M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J. clin. Microbiol, 1997, 35 : 1842-6.
29. MIDOLO P.D., KORMAN M.G., TURNIDGE J.D., LAMBERT J.R. Helicobacter pylori resistance to tetracycline. Lancet, 1996, 347 : 1194-5.
30. OLDENBREIT S., TILL M., HAAS R. Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence. Mol. Microbiol., 1996, 20 : 361-73.
31. DORE M.P., SEPULVADA A.R., MURA I., REALDI G., OSATO M.S., GRAHAM D.Y Explanation for variability of omeprazole-amoxicillin therapy ? Tolerance of Helicobacter pylori to amoxicillin. Gastroenterology, 1997, 112. A105.
32. DORE M.P., REALDI G., MURA I., OSATO M.S., GRAHAM D.Y., SEPULVADA A.R Amoxicillin resistant strains of Helicobacter pylori undergo reversible loss of resistance after storage. Gut, 1997, 41 (Suppl. 1) : A8.
33. WEISSFELD A., SIMMONS D., ROSE P., KIDD S., LUKASIK N., SIEPMAN N. Susceptibility of Helicobacter pylori to clarithromycin and amoxicillin in the US Gastroenterology, 1997, 112 : A329.
34. JAUP B.H., BRANDBERG A , STENQUIST B., NORRBY A Prevalence of antibiotic resistant H pylori strains among Swedish and immigrant patients with peptic ulcer disease and dyspepsia in Gothenburg. A consecutive study from an open access endoscopy center. Gut, 1997, 41 (Suppl. 1) : A39.
35. HARTZEN-HARTVIG S.H., ANDERSEN L.P., BREMMELGAARD A. et al. Antimicrobial susceptibility testing of 230 Helicobacter pylori strains . importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother., 1997, 41 : 2634-9.
36. TILLENBURG B., SIEHOFF S , BECKER T., PEITZ U., BORSCH G., LABENZ J Helicobacter pylori. pretherapeutic resistance status in Germany (Ruhr area). Z. Gastroenterol, 1997, 35 : 165-9.
37. VAN ZWET M , DE BOER W.A , SCHNEEBERGER P.M., WEEL J., JANSZ A R., THIS J.C. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin resistance in the Netherlands. Eur. J. Clin. Microbiol. Infect. Dis., 1996, 15 : 861-4.
38. XIA H.X , BUCKLEY M., KEANE C.T., O'MORAIN C.A. Clarithromycin resistance in Helicobacter pylori : prevalence in untreated dyspeptic patients and stability in vitro. J. Antimicrob. Chemother., 1996, 37 : 473-81.
39. LOPEZ-BREA M , MARTINEZ M.J., DOMINGO D, SANCHEZ ROMERO I., SANZ J.C., ALARCON T Evolution of the resistance to several antibiotics in H. pylori over a 4 year period. Gut, 1995, 37 (Suppl. 1) : A97
40. BROUTET N., GUILLON F., SAUTY E., LETHUAIRE D., MÉGRAUD F Observatoire de la sensibilité in vitro de Helicobacter pylori aux antibiotiques. Proceedings of the annual meeting on Helicobacter pylori : actualités 1998, Groupe d'Etudes Français des Helicobacters, 1998, Jan. 30, Institut Pasteur, Paris
41. ROZYNEK E., DZIERNANOWSAK D., CELINSKA-CEDRO D., JELJASZEWICZ J. Primary resistance to metronidazole and other antibiotics of Helicobacter pylori isolated from children in Poland. Eur. J. Clin. Microbiol. Infect Dis., 1997, 16 : 943-4.
42. XIA H.X., KEANE C T., O'MORAIN C.A A 5-year survey of metronidazole and clarithromycin resistance in clinical isolates of H pylori. Gut, 1996. 39 (Suppl 2) : A9.
43. VAKIL N., MCSORLEY D., HAHN B , CIOCIOLA A., WEBB D. Clarithromycin-resistant Helicobacter pylori in the United States. Gastroenterology, 1997, 112 : A182
44. CABRITA J., OLEASTRO M , MANHENTE A., CHAVES S., PIRES I. Evolution of Helicobacter pylori antibiotic resistance in Portugal (1990-1997). Gut, 1997, 41 (Suppl. 1) . A99.
45. REDDY R , OSATO M., GUTTIERREZ O., KIM G.J., GRAHAM D.Y. Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the US. Gastroenterology, 1996, 110 : A238.
46. GLUPCZYNSKI Y , and the European Study Group on Antibiotic Susceptibility of H. pylori. Results of a muticentre European survey in 1991 of metronidazole resistance in H. pylori. Eur. J. Clin Microbiol. Infect. Dis., 1992, 11 : 777-81.
47. TEO E K , FOCK K M., NG T.M. et al Primary and secondary metronidazole resistant Helicobacter pylori in an urban asian population Gut, 1996, 39 (Suppl. 2) : A13.
48. HACHEM C.Y, CLARRIDGE J.E., REDDY R. et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diag. Microbiol. Infect. Dis., 1996, 24 : 37-41.
49. BOUCHARD S., BIRAC C., LAMOULIATTE H., FORESTIER S., MÉGRAUD F Correlation between the MICs of metronidazole on H pylori strains and the outcome of a lansoprazole-amoxicillin-metronidazole therapy. Gut, 1996, 39 (Suppl 2) : A6.
50. GRAHAM D.Y., DE BOER W.A., TYTGAT G.N.J. Choosing the best anti-H pylori therapy : effect of antimicrobial resistance. Am. J. Gastroenterol., 1996, 91 : 1072-6
51. DE BOER W A., TYTGAT G.N.J. To treat Helicobacter pylori infection . should treatment strategies be based on testing bacterial susceptibility ? A personal view point, Eur. J. Gastroenterol Hepatol., 1996, 8 : 709-16.
52. HENRIKSEN T.H , BRORSON O., SCHOYEN R., THORESEN T. Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori, Eur. J. Clin. Microbiol. Infect Dis , 1996, 15 : 484-8.
53. HENRIKSEN T.H , BRORSON O., SCHOYEN R., THORESEN T., LIA A. A simple method for determining metronidazole resistance of Helicobacter pylori. J. Clin. Microbiol., 1997, 35 . 1424-6.
54. GLUPCZYNSKI Y., VAN DEN BORRE C., GOUTIER S., BURETTE A , DEVASTER J M., BUTZLER J.P Evaluation of metronidazole and clarithromycin screening agar plates for in vitro susceptibility testing of H. pylori Gut, 1997, 41 (Suppl. A) : A2.
55. GLUPCZYNSKI Y., LABBE M., HANSEN W. CROKAERT F., YOURASSOWSKY E Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori J. Clin. Microbiol, 1991, 29 : 2072-5.
56. CEDERBRANT G., KAHIMETER G, LJUNGH A. The E-test for antimicrobial susceptibility testing of H. pylori. J. Antimicrob Chemother., 1993, 31 : 65-71.
57. LOGAN R.P.H., GUMMETT P.A., MISIEWICZ J.J., KARIM Q.N , WALKER M.M., BARON J.H. One week eradication regimen for Helicobacter pylori. Lancet. 1991. 338 : 1249-52.
58. RAUTELIN H., SEPPÄLÄ K., RENKONEN O., VAINIO U., KOSUNEN T U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob. Agents Chemother., 1992, 36 : 163-6.
59. BURETTE A., GLUPCZYNSKI Y , DEPREZ C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur. J. Gastroenterol. Hepatol., 1992, 4 : 817-23.
60. NOACH L A., LANGENBERG W.L., BERTOLA M A , DANKERT J., TYTGAT G N Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand. J. Infect. Dis., 1994, 26 : 321-7.
61. LERANG F., MOUM B , RAGNHILDSVEIT E., SANDVEI P.K., TOLAS P , HENRIKSEN M., BERGE T. Simplified ten days triple therapy for cure of Helicobacter pylori infection. Gastroenterology. 1997, 112 : A198.
62. LERANG F , MOUM B., HAUG J.B. et al Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease : does in vitro metronidazole resistance have any clinical relevance ? Am. J. Gastroenterol. 1997. 92 : 248-53.
63. THIJS J.C., VAN ZWET M., THIJS W.J., VAN DER WOUDEN E J., KOOY A. One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection : the significance of imidazole resistance. Aliment. Pharmacol. Ther., 1997, 11 : 305-9.
64. MIYAJI H., ITO S., AZUMA T. et al. The prevalence of the drug resistance in Helicobacter pylori and the effects of the resistance on eradication therapy in Japan. Gastroenterology, 1997, 112 : A222.
65. HARRIS A W., PRYCE D.I., GABE S.M et al. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment. Pharmacol. Ther., 1996, 10 : 1005-8.
66. MOAYYEDI P., TOMPKINS D.S., RAGUNATHAN P.L., AXON A.T.R. Relevance of metronidazole resistance in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut. 1996, 39 (Suppl. 2) : A7
67. LIND T., MÉGRAUD F., BARDHAN K.D. et al. The MACH2 study : Antimicrobial resistance in Helicobacter pylori therapy - The impact of omeprazole. Gut, 1997, 41 (Suppl. 1) : A89.
68. GEORGOPOULOS S., KARATAPANIS S., MENTIS A., MANOLATOS D., VRETOU V., ARTIKIS V. Comparison of two short-term, triple therapies based on clarithromycin in the eradication of Helicobacter pylori. Gastroenterology, 1997, 112 : A125.
69. BUCKLEY M.J.M., XIA H.X., HYDE D.M., KEANE C.T., O'MORAIN C.A. Metronidazolc resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance Dig. Dis. Sci., 1997, 42 . 2111-5.
70. PEITZ U., NUSCH A., TILLENBURG B. et al. Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole and clarithromycin. Gastroenterology. 1997. 112 : A255.
71. VAN DER HULST R.W.M., VAN DER ENDE A., HOMAN A., ROORDA P., DANKERT J., TYIGAT G N.J. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication Gut. 1998, 42 : 166-9
72. GRAHAM D.Y., HOOFMAN J., EL-ZIMAITY H.M T., GRAHAM D.P., OSATO M. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther., 1997, 11 : 935-8.
73. BURETTE A , GLUPCZYNSKI Y., DEPREZ C. et al. Omeprazole alone or in combination with clarithromycin for eradication of Helicobacter pylori : results of a randomized double-blind controlled study. Gastroenterology, 1993, 104 . A49.
74. CAYLA R ,ZERBIB F, TALBI P., MÉGRAUD F, LAMOULIATTE H. Pre and post-treatment clarithromycin resistance of Helicobacter pylori : a key factor of treatment failure Gut, 1995, 37 (Suppl 1) : A55.
75. SCHÜTZE K., HENTSCHEL E., HIRSCHL A.M. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. Eur. J. Gastroenterol. Hepatol., 1996, 8 : 41-6.
76. LAMOULIATTE H., CAYLA R., ZERBIB F., TALBI P., MEGRAUD F., DE MASCAREL A Triple therapy with PPI-amoxicillin-clarithromycin for H. pylori eradication : the optimal regimen in 1996. Gastroenterology, 1996, 110 : A171.
77. BURETTE A, GLUPCZYNSKI Y , DEPREZ C., RAMDANI B. Omeprazole plus amoxycillin plus clarithromycin therapy for Helicobacter pylori infection. Gut. 1995. 37 (Suppl. 1) : A89.
78. BURETTE A., LAMY V., RAMDANI B., CAPPELLI J., DEPREZ C , GLUPCZYNSKI Y. Lansoprazole (3O mg OD vs BID) with amoxicillin and clarithromycin to cure Helicobacter pylori infection. Gut. 1996, 39 (Suppl. 2) : A33.
79. WÜRZER H., RODRIGO L., STAMLER D. et al. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group Aliment. Pharmacol. Ther., 1997, 11 : 943-52.
80. TOMPKINS D.S., PERKIN J., SMITH C Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin Helicobacter. 1997. 2 (4) : 185-7.
81. DE BOER W.A., DRIESSEN W.M M., JANSZ A R., TYTGAT G.N.J. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet, 1995, 345 : 817-20.
82. HAN D.S., CHO Y.J., SOHN J.H., PARK K.N., KANG J.O. Antimicrobial resistance of Helicobacter pylori in Korean duodenal ulcer patients. Gastroenterology. 1997, 112 : A138.
83. KATELARIS P.H., NGUYEN T.V., ROBERTSON G , SEOW F., BRADBURY R., NGU M.C. Metronidazole resistance in a cosmopolitan cohort of Australian dyspeptic patients Gut, 1997, 41 (Suppl 1) : A10.
84. BEST L M., HALDANE D.J , BEZANSON G.S., VELDHUYZEN VAN ZANTEN S.J. Helicobacter pylori. primary susceptibility to clarithromycin in vitro in Nova Scotia. Can. J. Gastroenterol., 1997,11 : 298-300.
85. DIBILDOX M., DEHESA M., LARISH J et al Helicobacter pylori antibiotic resistance in a mexican population with acute duodenal ulcer Gastroenterology, 1997, 112 : A102.